Search results
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 3 days agoThough it might be tempting to invest in stocks that have largely been in tandem with the broader...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 6 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 6 days ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...
Moderna to Present at Upcoming Conferences in May/June 2024
The Joplin Globe· 3 days agoA replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation. Moderna is a leader in the creation of the ...
Moderna’s mRNA dreams meet reality with first post-Covid shot
Boston.com· 7 days agoModerna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoProofPilot, the industry's premier platform for patient & site automation, guidance, and seamless execution, announces today its double victory alongside esteemed partner Moderna< ...
US FDA pushes decision on Moderna’s RSV vaccine to end of this month
WHTC 1450 Holland· 6 days ago(Reuters) - The U.S. Food and Drug Administration has pushed back its decision on Moderna's...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Top Stock Movers Now: TSMC, Moderna, Sweetgreen, and More
Investopedia· 6 days agoU.S. equities were mixed at midday, as the markets reacted to corporate headlines and report showing...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 4 days agoUltimately, it depends on when you got your last dose. In fall, an updated COVID vaccine was...